Cover Image

Editorial: Non-Dopaminergic Systems in Parkinson's Disease

Saved in:

Bibliographic Details
Main Authors:	Cristina Miguelez (Author), Philippe De Deurwaerdère (Author), Véronique Sgambato (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Noradrenergic System in Parkinson's Disease
by: Elena Paredes-Rodriguez, et al.
Published: (2020)

Non-Dopaminergic Systems in Parkinson's Disease
Published: (2020)

Parkinson's disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
by: Tomás González-Hernández, et al.
Published: (2010)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
by: Sara Redenšek, et al.
Published: (2019)

PARKINSON'S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014)

Endocannabinoid modulation of dopaminergic motor circuits
by: Teresa eMorera-Herreras, et al.
Published: (2012)

Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
by: Lars eBrichta, et al.
Published: (2014)

Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation
by: Sergio Vegas-Suárez, et al.
Published: (2022)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson's Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease
by: Yi Zhao, et al.
Published: (2018)

Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease
by: Shigeki Hirano
Published: (2021)

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
by: Nicoletta Schintu, et al.
Published: (2020)

CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease
by: Yuejun Wang, et al.
Published: (2022)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease Models
by: Matthew L. Neal, et al.
Published: (2023)

Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease
by: Colleen S. Stein, et al.
Published: (2022)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease
by: Xavier ed'Anglemont De Tassigny, et al.
Published: (2015)

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson's Disease; Possible Involvement of Dopaminergic Neurotransmission
by: Reza Vajdi-Hokmabad, et al.
Published: (2017)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson's Disease
by: Leilei Chen, et al.
Published: (2021)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP
by: Juan M. Viveros-Paredes, et al.
Published: (2017)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
by: Young Cheul Chung, et al.
Published: (2013)

Protection Against Dopaminergic Neurodegeneration in Parkinson's Disease-Model Animals by a Modulator of the Oxidized Form of DJ-1, a Wild-type of Familial Parkinson's Disease-Linked PARK7
by: Masatoshi Inden, et al.
Published: (2011)

Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway
by: Hu M, et al.
Published: (2018)

Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6/JAK2/STAT3 Pathway in Parkinson's Disease Model
by: Xueping Yang, et al.
Published: (2022)

Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism
by: Song Ju-Xian, et al.
Published: (2012)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
by: Katrine Fabricius, et al.
Published: (2017)

Caffeine reduces deficits in mechanosensation and locomotion induced by L-DOPA and protects dopaminergic neurons in a transgenic Caenorhabditis elegans model of Parkinson's disease
by: Rafael Vincent M. Manalo, et al.
Published: (2020)

Lolita de Vladimir Nabokov: historia de una obsesión (fílmica)
by: Katixa Agirre Miguélez
Published: (2010)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014)

Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
by: Jacob Raber, et al.
Published: (2023)

Editorial: Neuroprotection and Disease Modification in Parkinson's Disease
by: Matilde Otero-Losada, et al.
Published: (2021)

Dopaminergic Mechanisms in Adhd
by: J Gordon Millichap, et al.
Published: (2014)

N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson's Disease Rat Model
by: Rita Caridade-Silva, et al.
Published: (2023)

<i>Rumex japonicus</i> Houtt. Protects Dopaminergic Neurons by Regulating Mitochondrial Function and Gut-Brain Axis in In Vitro and In Vivo Models of Parkinson's Disease
by: Hee-Young Kim, et al.
Published: (2022)

Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review
by: Christos Koros, et al.
Published: (2024)

The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
by: Pia M. Vidal, et al.
Published: (2020)

Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting
by: Philippe De Deurwaerdère, et al.
Published: (2020)

NON-MOTOR SYMPTOMS OF PARKINSON DISEASE
by: N.A. ZARIPOV, et al.
Published: (2021)

Molecular imaging in Parkinson's disease
by: Polito, Cristina
Published: (2011)

Molecular imaging in Parkinson's disease
by: Polito, Cristina
Published: (2011)